Every law firm that pursues aggressive growth eventually confronts the same uncomfortable tension between expanding its reach and protecting what made it worth growing in the first place. Scott Rahn, Founding Partner
Private equity’s long-anticipated move into the legal industry has taken a significant step forward with a landmark reported deal worth $700 million. Charlesbank Capital Partners is reported to have struck a deal
More
Treasury Secretary Scott Bessent faces a growing credibility problem in the government bond market after two early interventions failed to deliver lasting calm. Bessent insisted Thursday he has multiple tools at his
More
GfK’s consumer confidence index climbed to -14 in August, rising three points from the previous month’s net score. The rise marks the fourth consecutive month of improving consumer sentiment, with confidence growing
More
Heidi Overton, currently serving as deputy director of domestic policy at the White House, is reportedly in line to become the next FDA commissioner. President Trump is expected to put forward Overton’s
More
The DC Circuit Court has unanimously upheld the EPA’s designation of two widely used chemical compounds as hazardous substances under federal environmental law. The ruling, handed down on August 18, confirmed the
More
Judge Roy Altman of the Southern District of Florida is facing a formal judicial complaint filed with the Judicial Council of the Eleventh Circuit over his conduct. The complaint centres on Altman’s
More
Wall Street retreated to its lowest levels in two weeks as rising bond yields and disappointing signals from Walmart combined to pressure equity markets broadly. The sell-off reflected growing investor anxiety about
More
Hays plc (HAS) tumbled on the FTSE 250 after the recruitment firm reported a significant loss, dragging its shares sharply lower during the trading session. The London-listed staffing group has faced mounting
More
Aurinia Pharmaceuticals (AUPH) has reached a patent infringement settlement with Teva Pharmaceuticals (TEVA) over its flagship lupus drug Lupkynis (voclosporin). The deal should prevent Teva from launching a generic version of voclosporin
More
British American Tobacco (BTI) serves as a stark warning that resolving enforcement actions with US authorities does not close the door on further legal exposure worldwide. Most corporations operating globally consider government
More